CERS vs. VCYT
CERS (Cerus Corporation) and VCYT (Veracyte, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, CERS returned -11.37%/yr vs 25.08%/yr for VCYT. Their 0.42 correlation means their historical movements had little consistent relationship.
Performance
CERS vs. VCYT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CERS achieves a 4.37% return, which is significantly lower than VCYT's 10.02% return. Over the past 10 years, CERS has underperformed VCYT with an annualized return of -11.37%, while VCYT has yielded a comparatively higher 25.08% annualized return.
CERS
- 1D
- -25.61%
- 1M
- -31.96%
- 6M
- -7.73%
- YTD
- 4.37%
- 1Y
- 69.29%
- 3Y*
- -10.21%
- 5Y*
- -15.67%
- 10Y*
- -11.37%
- ALL TIME*
- -5.73%
VCYT
- 1D
- -22.52%
- 1M
- -18.85%
- 6M
- 21.64%
- YTD
- 10.02%
- 1Y
- 95.94%
- 3Y*
- 19.65%
- 5Y*
- 0.78%
- 10Y*
- 25.08%
- ALL TIME*
- 10.48%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $7.50M | $7.32M | $7.35M | |
VCYT Veracyte, Inc. | $76.67M | $68.47M | $67.41M |
CERS vs. VCYT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CERS Cerus Corporation | 4.37% | 33.77% | -28.70% | -40.82% | -46.40% | -1.59% | 63.98% | -16.77% | 50.00% | -22.30% |
VCYT Veracyte, Inc. | 10.02% | 6.31% | 43.95% | 15.93% | -42.40% | -15.82% | 75.29% | 121.94% | 92.65% | -15.63% |
Correlation
The correlation between CERS and VCYT is 0.41, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.41 |
Correlation (3Y) Balances recent behavior with more history. | 0.48 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.57 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.48 |
Correlation (All Time) Calculated using the full available price history since Oct 30, 2013 | 0.42 |
The correlation between CERS and VCYT shifts across timeframes, from 0.41 (1 year) to 0.57 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
CERS:
$430.79M
VCYT:
$3.70B
CERS:
-$0.03
VCYT:
$1.41
CERS:
1.83
VCYT:
6.68
CERS:
6.00
VCYT:
2.73
CERS:
$227.78M
VCYT:
$561.90M
CERS:
$121.55M
VCYT:
$405.67M
CERS:
$2.48M
VCYT:
$126.58M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CERS vs. VCYT — Risk / Return Rank
CERS
VCYT
CERS vs. VCYT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cerus Corporation (CERS) and Veracyte, Inc. (VCYT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CERS | VCYT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.64 | ||
| Sortino ratioReturn per unit of downside risk | -0.71 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.32 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | 1.78 | 2.49 | -0.70 |
| Martin ratioReturn relative to average drawdown | 4.50 | 5.48 | -0.98 |
Loading charts...
Drawdowns
CERS vs. VCYT - Drawdown Comparison
The maximum CERS drawdown since its inception was -99.28%, which is greater than VCYT's maximum drawdown of -81.19%. Use the drawdown chart below to compare losses from any high point for CERS and VCYT.
Loading charts...
Drawdown Indicators
| CERS | VCYT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.28% | -81.19% | -18.09% |
Max Drawdown (1Y)Largest decline over 1 year | -38.32% | -39.23% | +0.91% |
Max Drawdown (3Y)Largest decline over 3 years | -52.46% | -50.09% | -2.37% |
Max Drawdown (5Y)Largest decline over 5 years | -85.37% | -71.54% | -13.83% |
Max Drawdown (10Y)Largest decline over 10 years | -86.45% | -81.19% | -5.26% |
Current DrawdownCurrent decline from peak | -97.33% | -43.08% | -54.25% |
Average DrawdownAverage peak-to-trough decline | -81.46% | -48.14% | -33.32% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.15% | 17.77% | -2.62% |
Volatility
CERS vs. VCYT - Volatility Comparison
Cerus Corporation (CERS) has a higher volatility of 32.20% compared to Veracyte, Inc. (VCYT) at 29.33%. This indicates that CERS's price experiences larger fluctuations and is considered to be riskier than VCYT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CERS | VCYT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 32.20% | 29.33% | +2.87% |
Volatility (6M)Calculated over the trailing 6-month period | 59.83% | 48.25% | +11.58% |
Volatility (1Y)Calculated over the trailing 1-year period | 79.08% | 65.08% | +14.00% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 70.84% | 64.89% | +5.95% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 63.78% | 62.58% | +1.20% |
Dividends
CERS vs. VCYT - Dividend Comparison
Neither CERS nor VCYT has paid dividends to shareholders.
Financials
CERS vs. VCYT - Financials Comparison
This section allows you to compare key financial metrics between Cerus Corporation and Veracyte, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CERS vs. VCYT - Profitability Comparison
CERS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Cerus Corporation reported a gross profit of 29.53M and revenue of 57.44M. Therefore, the gross margin over that period was 51.4%.
VCYT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Veracyte, Inc. reported a gross profit of 109.13M and revenue of 150.32M. Therefore, the gross margin over that period was 72.6%.
CERS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Cerus Corporation reported an operating income of -1.86M and revenue of 57.44M, resulting in an operating margin of -3.2%.
VCYT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Veracyte, Inc. reported an operating income of 21.78M and revenue of 150.32M, resulting in an operating margin of 14.5%.
CERS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Cerus Corporation reported a net income of -2.94M and revenue of 57.44M, resulting in a net margin of -5.1%.
VCYT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Veracyte, Inc. reported a net income of 25.49M and revenue of 150.32M, resulting in a net margin of 17.0%.
Frequently Asked Questions
CERS and VCYT have a correlation of 0.41, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CERS has higher volatility (32.20%) compared to VCYT (29.33%). In terms of maximum drawdown, CERS dropped -99.28% vs VCYT's -81.19%.
VCYT currently has the higher Sharpe Ratio (1.50 vs 0.86), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CERS and VCYT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer